MSAM
IBB icon

Moloney Securities Asset Management’s iShares Biotechnology ETF IBB Stock Holding History

Moloney Securities Asset Management’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-2,110
Closed -$307K – 491
2024
Q3 		$307K Sell
2,110
-290
-12% -$42K 0.04% 351
2024
Q2 		$329K Sell
2,400
-90
-4% -$12K 0.05% 333
2024
Q1 		$342K Hold
2,490
– – 0.05% 325
2023
Q4 		$338K Buy
2,490
+55
+2% +$6.71K 0.05% 318
2023
Q3 		$298K Sell
2,435
-174
-7% -$22.1K 0.05% 316
2023
Q2 		$331K Sell
2,609
-241
-8% -$31.3K 0.06% 305
2023
Q1 		$368K Buy
2,850
+29
+1% +$3.8K 0.07% 277
2022
Q4 		$370K Buy
2,821
+29
+1% +$3.75K 0.08% 260
2022
Q3 		$326K Sell
2,792
-54
-2% -$6.71K 0.08% 256
2022
Q2 		$335K Sell
2,846
-9
-0.3% -$1.07K 0.08% 249
2022
Q1 		$372K Buy
2,855
+55
+2% +$7.16K 0.07% 259
2021
Q4 		$427K Buy
2,800
+28
+1% +$4.33K 0.07% 269
2021
Q3 		$448K Buy
2,772
+120
+5% +$20.2K 0.08% 259
2021
Q2 		$434K Buy
2,652
+175
+7% +$27K 0.08% 256
2021
Q1 		$373K Hold
2,477
– – 0.07% 264
2020
Q4 		$375K Buy
2,477
+391
+19% +$55.9K 0.08% 245
2020
Q3 		$282K Buy
2,086
+235
+13% +$31.9K 0.07% 250
2020
Q2 		$253K Buy
+1,851
New +$236K 0.07% 244
2020
Q1 		– Sell
-1,865
Closed -$225K – 313
2019
Q4 		$225K Buy
+1,865
New +$208K 0.07% 304
2019
Q3 		– Sell
-1,989
Closed -$217K – 340
2019
Q2 		$217K Sell
1,989
-123
-6% -$13.1K 0.07% 273
2019
Q1 		$236K Buy
+2,112
New +$232K 0.08% 250
2018
Q4 		– Sell
-1,990
Closed -$243K – 298
2018
Q3 		$243K Sell
1,990
-1,310
-40% -$154K 0.08% 240
2018
Q2 		$362K Buy
3,300
+90
+3% +$9.63K 0.14% 185
2018
Q1 		$343K Sell
3,210
-85
-3% -$9.42K 0.14% 187
2017
Q4 		$352K Buy
3,295
+133
+4% +$14.2K 0.15% 174
2017
Q3 		$351K Sell
3,162
-150
-5% -$16K 0.16% 169
2017
Q2 		$342K Buy
3,312
+324
+11% +$31.9K 0.17% 163
2017
Q1 		$292K Buy
+2,988
New +$286K 0.15% 179

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Moloney Securities Asset Management's IBB Position: Q4 2024 in Review

Moloney Securities Asset Management sold out of iShares Biotechnology ETF (IBB) in Q4 2024, closing a stake of 2,110 shares — an estimated $307K sold.

Moloney Securities Asset Management first reported a position in IBB in Q1 2017 and held it in 28 quarters. The position peaked at $448K in Q3 2021. 874 funds tracked by Wall St. Rank hold IBB as of Q4 2024.

  • Moloney Securities Asset Management reported no remaining iShares Biotechnology ETF position as of Q4 2024 after selling out during the quarter.
  • Moloney Securities Asset Management sold 2,110 iShares Biotechnology ETF shares in Q4 2024, an estimated $307K.
  • Moloney Securities Asset Management first reported a position in iShares Biotechnology ETF in Q1 2017 and held it in 28 quarters.
  • Moloney Securities Asset Management's iShares Biotechnology ETF position peaked at $448K in Q3 2021.
  • 874 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q4 2024.

Based on Moloney Securities Asset Management's 13F filing for Q4 2024, filed 28 Jan 2025.